Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.

Absence of mucocutaneous involvement, lower LDAS predict remission in SLE

01 Nov 2019

Remission in patients with systemic lupus erythematosus (SLE) is predicted by the absence of mucocutaneous, renal and haematologic involvement, use of immunosuppressive drugs, and lower disease activity state (LDAS) early in the course of the disease, a study has shown. Additionally, older age predicts LDAS.

A total of 1,480 patients were included, among whom 902 were nonoptimally controlled at entry. Of these, 196 (21.7 percent) achieved remission and 314 (34.8 percent) achieved LDAS.

The following variables predicted a higher probability of remission: absence of mucocutaneous manifestations (hazard ratio [HR], 1.571, 95 percent CI, 1.064–2.320), absence of renal involvement (HR, 1.487, 1.067–2.073) and absence of haematologic involvement (HR, 1.354, 1.005–1.825); use of immunosuppressive drugs before the baseline visit (HR, 1.468, 1.025–2.105); and a lower SLE Disease Activity Index (SLEDAI) score at entry (HR, 1.028, 1.006–1.051 per 1-unit decrease).

Moreover, the predictors of LDAS included older age at entry (HR, 1.050, 1.004–1.098 per 5-year increase), absence of mucocutaneous manifestations (HR, 1.401, 1.016–1.930) and renal involvement (HR, 1.344, 1.049–1.721), and lower SLEDAI score at entry (HR, 1.025, 1.009–1.042).

The authors defined three disease activity states, as follows: remission (SLEDAI=0 and prednisone ≤5 mg/day and/or immunosuppressants [maintenance dose]); LDAS (SLEDAI ≤4, prednisone ≤7.5 mg/day and/or immunosuppressants [maintenance dose]); and nonoptimally controlled state (SLEDAI >4 and/or prednisone >7.5 mg/day and/or immunosuppressants [induction dose]).

Antimalarials were allowed in all groups. Patients with at least two SLEDAI reported and not optimally controlled at entry were included the analyses. Multivariable Cox regression models (stepwise selection procedure) were used to assess remission and LDAS.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.